-- 根據週三提交給香港交易所的文件，Joinn Laboratories（港交所代碼：6127，滬交所代碼：603127）公佈第一季歸屬於股東的淨利潤為2.384億元人民幣，較去年同期的4110萬元人民幣增長480%。 這家藥物研發公司在香港上市的股票在周四上午的交易中下跌超過6%。 每股收益為0.32元人民幣，高於去年同期的0.05元。 營收年增10%，從去年同期的2.873億元增至3.161億元。
Related Articles
Asia
Market Chatter: ASX's Equity Post-Trade Pricing Model Changes May Increase Revenue, UBS Says
Changes to ASX's (ASX:ASX) equity post-trade pricing model might raise revenues even if turnover moderates, according to UBS analyst Kieren Chidgey, the Australian Financial Review reported Thursday.Chidgey increased earnings forecasts by around 6% across fiscal year 2027 and fiscal year 2028. He expects futures revenue to exceed market forecasts by 10% to 11% over these years.UBS upgraded its recommendation to buy and raised the price target to AU$65.20 per share.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:ASX
Asia
China Railway Construction's Profit Falls 15% in Q1; Hong Kong Shares Slip 3%
China Railway Construction (HKG:1186, SHA:601186) posted net profit attributable to shareholders of 4.39 billion yuan for the first quarter, down 15% from 5.15 billion yuan a year earlier, according to a Wednesday Hong Kong bourse filing.The railway infrastructure developer's Hong Kong shares declined 3% in Thursday afternoon trade.Earnings per share came in at 0.28 yuan, compared with 0.34 yuan a year earlier.Revenue fell 9.8% to 231.6 billion yuan from 256.8 billion yuan in the prior-year period.
$HKG:1186$SHA:601186
Asia
Mphasis Clocks Gains in Fiscal Q4 Consolidated Profit; Shares Up 3%
Mphasis (NSE:MPHASIS, BOM:526299) recorded a rise in its consolidated attributable profit to 5.10 billion Indian rupees in the fiscal fourth quarter ended March 31 from 4.46 billion rupees a year ago.The company's shares were up nearly 3% in Thursday's trade.Earnings per share climbed to 26.68 rupees compared with the year-ago figure of 23.41 rupees, according to a Wednesday filing to the Indian stock exchanges by the technology company.Revenue from operations in fiscal Q4 increased to 42.4 billion rupees from 37.1 billion rupees a year earlier.The board recommended a final dividend of 62 rupees per share for the fiscal year ended March 31.
$BOM:526299$NSE:MPHASIS